The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis

被引:14
作者
Heald, Adrian H. [1 ,2 ,3 ]
Jenkins, David A. [4 ,5 ]
Williams, Richard [4 ,5 ]
Sperrin, Matthew [4 ,5 ]
Fachim, Helene [1 ,2 ,3 ]
Mudaliar, Rajshekhar N. [1 ,2 ,3 ]
Syed, Akheel [1 ,2 ,3 ]
Naseem, Asma [1 ,2 ,3 ]
Gibson, J. Martin [1 ,2 ,3 ]
Davies, Kelly A. Bowden [6 ]
Peek, Niels [4 ,5 ]
Anderson, Simon G. [7 ,8 ]
Peng, Yonghong [9 ]
Ollier, William [9 ]
机构
[1] Univ Manchester, Sch Med, Manchester, Lancs, England
[2] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[3] Salford Royal NHS Fdn Trust, Dept Diabet & Endocrinol, Salford, Lancs, England
[4] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol, Div Informat Imaging & Data Sci, Manchester, Lancs, England
[5] Univ Manchester, NIHR Greater Manchester Patient Safety Translat R, Manchester, Lancs, England
[6] Manchester Metropolitan Univ, Musculoskeletal Sci & Sports Med Res Ctr, Dept Sport & Exercise Sci, Manchester, Lancs, England
[7] Univ West Indies, Cavehill Campus, Bridgetown, Barbados
[8] Univ Manchester, Fac Biol Med & Hlth, Div Cardiovasc Sci, Manchester, Lancs, England
[9] Manchester Metropolitan Univ, Fac Sci & Engn, Manchester, Lancs, England
关键词
SARS-CoV-2; Covid-19; T1DM; T2DM; Hospital admission; COVID-19; COMORBIDITIES; OUTCOMES; DISEASE;
D O I
10.1007/s13300-022-01230-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Since early 2020 the whole world has been challenged by the SARS-CoV-2 virus and the associated global pandemic (Covid-19). People with diabetes are particularly at high risk of becoming seriously unwell after contracting this virus. Methods This population-based study included people living in the Greater Manchester conurbation who had a recorded diagnosis of type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) and subsequent Covid-19 infection. Each individual with T1DM (n = 862) or T2DM (n = 13,225) was matched with three Covid-19-infected non-diabetes controls. Results For individuals with T1DM, hospital admission rate in the first 28 days after a positive Covid-19 test was 10% vs 4.7% in age/gender-matched controls [relative risk (RR) 2.1]. For individuals with T2DM, hospital admission rate after a positive Covid-19 test was 16.3% vs 11.6% in age/gender-matched controls (RR 1.4). The average Townsend score was higher in T2DM (1.8) vs matched controls (0.4), with a higher proportion of people with T2DM observed in the top two quintiles of greatest disadvantage (p < 0.001). For Covid-19-infected individuals with T1DM, factors influencing admission likelihood included age, body mass index (BMI), hypertension, HbA1c, low HDL-cholesterol, lower estimated glomerular filtration rate (eGFR), chronic obstructive pulmonary disease (COPD) and being of African/mixed ethnicity. In Covid-19-infected individuals with T2DM, factors related to a higher admission rate included age, Townsend index, comorbidity with COPD/asthma and severe mental illness (SMI), lower eGFR. Metformin prescription lowered the likelihood. For multivariate analysis in combined individuals with T2DM/controls, factors relating to higher likelihood of admission were having T2DM/age/male gender/diagnosed COPD/diagnosed hypertension/social deprivation (higher Townsend index) and non-white ethnicity (all groups). Conclusion In a UK population we have confirmed a significantly higher likelihood of admission in people with diabetes following Covid-19 infection. A number of factors mediate that increased likelihood of hospital admission. For T2DM, the majority of factors related to increased admission rate are common to the general population but more prevalent in T2DM. There was a protective effect of metformin in people with T2DM.
引用
收藏
页码:1007 / 1021
页数:15
相关论文
共 25 条
  • [1] Diabetes and COVID-19: A systematic review on the current evidences
    Abdi, Alireza
    Jalilian, Milad
    Sarbarzeh, Pegah Ahmadi
    Vlaisavljevic, Zeljko
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 166
  • [2] Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
    Barron, Emma
    Bakhai, Chirag
    Kar, Partha
    Weaver, Andy
    Bradley, Dominique
    Ismail, Hassan
    Knighton, Peter
    Holman, Naomi
    Khunti, Kamlesh
    Sattar, Naveed
    Wareham, Nicholas J.
    Young, Bob
    Valabhji, Jonathan
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (10) : 813 - 822
  • [3] Vitamin D and COVID-19
    Bilezikian, John P.
    Bikle, Daniel
    Hewison, Martin
    Lazaretti-Castro, Marise
    Formenti, Anna Maria
    Gupta, Aakriti
    Madhavan, Mahesh, V
    Nair, Nandini
    Babalyan, Varta
    Hutchings, Nicholas
    Napoli, Nicola
    Accili, Domenico
    Binkley, Neil
    Lamdry, Donald W.
    Giustina, Andrea
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2020, 183 (05) : R133 - R147
  • [4] Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
    Cariou, Bertrand
    Hadjadj, Samy
    Wargny, Matthieu
    Pichelin, Matthieu
    Al-Salameh, Abdallah
    Allix, Ingrid
    Amadou, Coralie
    Arnault, Gwenaelle
    Baudoux, Florence
    Bauduceau, Bernard
    Borot, Sophie
    Bourgeon-Ghittori, Muriel
    Bourron, Olivier
    Boutoille, David
    Cazenave-Roblot, France
    Chaumeil, Claude
    Cosson, Emmanuel
    Coudol, Sandrine
    Darmon, Patrice
    Disse, Emmanuel
    Ducet-Boiffard, Amelie
    Gaborit, Benedicte
    Joubert, Michael
    Kerlan, Veronique
    Laviolle, Bruno
    Marchand, Lucien
    Meyer, Laurent
    Potier, Louis
    Prevost, Gaetan
    Riveline, Jean-Pierre
    Robert, Rene
    Saulnier, Pierre-Jean
    Sultan, Ariane
    Thebaut, Jean-Francois
    Thivolet, Charles
    Tramunt, Blandine
    Vatier, Camille
    Roussel, Ronan
    Gautier, Jean-Francois
    Gourdy, Pierre
    [J]. DIABETOLOGIA, 2020, 63 (08) : 1500 - 1515
  • [5] Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study
    Clift, Ash K.
    Coupland, Carol A. C.
    Keogh, Ruth H.
    Diaz-Ordaz, Karla
    Williamson, Elizabeth
    Harrison, Ewen M.
    Hayward, Andrew
    Hemingway, Harry
    Horby, Peter
    Mehta, Nisha
    Benger, Jonathan
    Khunti, Kamlesh
    Spiegelhalter, David
    Sheikh, Aziz
    Valabhji, Jonathan
    Lyons, Ronan A.
    Robson, John
    Semple, Malcolm G.
    Kee, Frank
    Johnson, Peter
    Jebb, Susan
    Williams, Tony
    Hippisley-Cox, Julia
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
  • [6] Measuring disadvantage: Changes in the underprivileged area, Townsend, and Carstairs scores 1981-91
    Dolan, SA
    Jarman, B
    Bajekal, M
    Davies, PM
    Hart, D
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1995, 49 : S30 - S33
  • [7] Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the US
    Ebekozien, Osagie A.
    Noor, Nudrat
    Gallagher, Mary Pat
    Alonso, G. Todd
    [J]. DIABETES CARE, 2020, 43 (08) : E83 - E85
  • [8] Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study
    Hippisley-Cox, Julia
    Coupland, Carol A. C.
    Mehta, Nisha
    Keogh, Ruth H.
    Diaz-Ordaz, Karla
    Khunti, Kamlesh
    Lyons, Ronan A.
    Kee, Frank
    Sheikh, Aziz
    Rahman, Shamim
    Valabhji, Jonathan
    Harrison, Ewen M.
    Sellen, Peter
    Haq, Nazmus
    Semple, Malcolm G.
    Johnson, Peter W. M.
    Hayward, Andrew
    Nguyen-Van-Tam, Jonathan S.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [9] Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
  • [10] COVID-19: A review of therapeutic strategies and vaccine candidates
    Izda, Vladislav
    Jeffries, Matlock A.
    Sawalha, Amr H.
    [J]. CLINICAL IMMUNOLOGY, 2021, 222